| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |